Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented

Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented

Exocrine pancreatic ductal adenocarcinoma, simply referred to as pancreatic cancer (PC) has the worst prognosis of any malignancy. Despite recent advances in the use of adjuvant chemotherapy in PC, the prognosis remains poor, with fewer than 8% of patients being alive at 5 years after diagnosis. The...

Full description

Bibliographic Details
Main Authors: Dominique Farge, Barbara Bournet, Thierry Conroy, Eric Vicaut, Janusz Rak, George Zogoulous, Jefferey Barkun, Mehdi Ouaissi, Louis Buscail, Corinne Frere
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
pancreatic cancer
venous thromboembolism
thromboprophylaxis
low-molecular weight heparin
direct oral anticoagulant
survival
Online Access:https://www.mdpi.com/2072-6694/12/3/618

Internet

https://www.mdpi.com/2072-6694/12/3/618

Similar Items